Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125653742 | 12565374 | 2 | F | 201602 | 20160713 | 20160718 | 20160725 | EXP | SE-MPA-2016-003796 | SE-TEVA-674962ACC | TEVA | 67.00 | YR | M | Y | 0.00000 | 20160725 | MD | SE | SE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125653742 | 12565374 | 1 | PS | METHOTREXATE (METHOTREXATE SODIUM) | METHOTREXATE SODIUM | 1 | N | U | 81099 | 15 | MG | TABLET | /wk | ||||||
| 125653742 | 12565374 | 2 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125653742 | 12565374 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125653742 | 12565374 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125653742 | 12565374 | Acute kidney injury | |
| 125653742 | 12565374 | Hepatitis | |
| 125653742 | 12565374 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125653742 | 12565374 | 1 | 20141007 | 20160531 | 0 | |
| 125653742 | 12565374 | 2 | 201605 | 0 |